Formulation and Optimization of Captopril Sublingual Tablet Using D-Optimal DesignSublingual Tablet Using D-Optimal Design
Authors
Abstract
The objective of the current study was to develop and optimize a sublingual tablet formulation of captopril which is an effective drug in the treatment of hypertension. Captopril containing tablets were prepared by direct compression method using different ingredients such as polyvinyl pyrrolidone, starch 1500, sodium starch glycolate and lactose (independent variables) and magnesium stearate, talc and aspartame (fixed components). Tablets were evaluated for the physical properties including hardness, disintegration time and friability which were considered as responses in a D-optimal experimental plan. Results were statistically examined using special cubic model and polynomial mathematical equations and found to be statistically significant (p<0.05) for disintegration time and friability data. Meanwhile linear model was best fitted with hardness data. The obtained results were used to generate optimized overlay plot. The physical data from the numerical optimization were verified and found to be very close to those predicted from the regression analysis. Additional experiments including drug content, in vitro drug dissolution rate and accelerated stability studies were also performed on the optimum formulation. All results were in accordance with the requirements of a sublingual tablet.
Copyright
© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Formulation and Evaluation of Orally Disintegrating Tablets of Captopril Using Natural Super Disintegrants
Shahtalebi MA, Tabbakhian M, Sarbolookzadeh Harandi N. Formulation and Evaluation of Orally Disintegrating Tablets of Captopril Using Natural Super Disintegrants. J Rep Pharm Sci. 2014;3(1):e147727. doi:
Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design
Soroush H, Ghorbani-Bidkorbeh F, Mortazavi SA, Mehramizi A. Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design. Iran J Pharm Res. 2018;17(4):e124870. doi: https://doi.org/10.22037/ijpr.2018.2318
Design, Formulation and Evaluation of Its Physiochemical Properties of Acetaminophen, Ibuprofen and Caffeine as Effervescent Tablet
Aslani A, Daliri A. Design, Formulation and Evaluation of Its Physiochemical Properties of Acetaminophen, Ibuprofen and Caffeine as Effervescent Tablet. J Rep Pharm Sci. 2016;5(2):e147652. doi:
Design, Formulation and Physicochemical Evaluation of Acetaminophen Effervescent Tablets
Aslani A, Eatesam P. Design, Formulation and Physicochemical Evaluation of Acetaminophen Effervescent Tablets. J Rep Pharm Sci. 2013;2(2):e147747. doi:
Formulation and In-vitro Characterization of Sustained Release Matrix Type Ocular Timolol Maleate Mini-Tablet
Mortazavi SA, Jafariazar Z, Ghadjahani Y, Mahmoodi H, Mehtarpour F. Formulation and In-vitro Characterization of Sustained Release Matrix Type Ocular Timolol Maleate Mini-Tablet. Iran J Pharm Res. 2014;13(1):e125456. doi: https://doi.org/10.22037/ijpr.2014.1435
- Scopus by DOI: 0
Last Update: 1 month ago
- Scopus by Title: 0
Last Update: 1 month ago
- Scopus by Title (Ref): 0
Last Update: 1 month ago
- CrossRef: 0
Last Update: 6 days ago